“Synergistic Growth Inhibition by Sorafenib and Vitamin K2 in Human Hepatocellular Carcinoma Cells”. Clinics, vol. 67, no. 9, Sept. 2012, pp. 1093-9, https://doi.org/10.6061/clinics/2012(09)18.